Recent Research Funding

“Our faculty have great success securing competitive grants that allow us to further our innovative research,” says John Canty Jr., division chief, with fellow Amanda Ribbeck.

We receive funding from a variety of sources that recognize the value of our high-impact research.

With the support of government agencies, foundations, institutes and industry, our faculty make significant contributions to patient health and our understanding of cardiovascular disease.

We’ve been awarded grants from numerous funding sources, including:

  • National Institutes of Health
  • American Heart Association
  • Veterans Health Administration

Some of our recent research efforts, listed by faculty investigator, are as follows:

  • VA Merit Review, 2IO1BX002659, Preventing and Reversing Interstitial Fibrosis in HFpEF. John Canty, Jr. (Principal Investigator). Department of Veterans Affairs. $709,984. 7/1/2020-6/1/2026.
  • Immunomodulation of Galectin-3 to Prevent Radiation-Induced Myocardial Fibrogenesis. Umesh Sharma (Principal Investigator). NHLBI. $1,726,588. 3/1/2021-3/1/2026.
  • Prediction of Arrhythmic Events with Positron Emission Tomography - II (PAREPET II). John Canty, Jr. (Co-Principal Investigator). National Heart Lung and Blood Institute - NHLBI. $3,726,616. 11/1/2016-12/1/2023.
  • The Functional Role of Exosomes in Stem Cell-Mediated Cardiac Repair. Jennifer Lang (Principal Investigator). Veteran‘s Administration. $1,389,635. 10/1/2018-9/1/2023.
  • The Functional Role of Exosomes in Stem Cell Mediated Cardiac Repair. Jennifer Lang (Principal Investigator). NIH/NHLBI. $1,006,430. 12/1/2017-11/1/2022.
  • PAREPET II: Prediction of Arrhythmic Events with Positron Emission Tomography II. Thomas Cimato (Co-Investigator). NIH/NHLBI. 4/1/2016-11/1/2022.
  • K12 HL138052 National Heart Lung and Blood Institute, UB Clinical Scholar Program in implementation science to achieve triple aims. John Canty, Jr. (Co-Principal Investigator), Ranjit Singh (Co-Principal Investigator). UB Clinical Scholar Program in Implementation Science to Achieve Triple Aims. $1,022,277. 9/1/2017-8/1/2022.
  • National Institutes of Health/NHLBI, K08. Umesh Sharma (Principal Investigator). NHLBI. $986,850. 7/1/2017-6/1/2022.
  • Improving the Translational Potential of Cell-Free Therapy for Heart Disease. Jennifer Lang (Principal Investigator). UB’s Seeds for Innovation in Successful Aging (SISA) Pilot Funding Program. 1/1/2022-1/1/2022.
  • Prediction ARrhythmic Events with Positron Emission Tomography - II (PAREPET-II). James Fallavollita (Co-Principal Investigator). NIH - NHLBI. 1/1/2016-12/1/2021.
  • Prediction of Arrhythmic Events with Positron Emission Tomography - II (PAREPET II). James Fallavollita (Co-Principal Investigator). National Heart Lung and Blood Institute - NHLBI. $3,726,616. 11/1/2016-12/1/2021.